Predictive Oncology Inc.

Good day, and thank you for standing by. Welcome to the Predictive Oncology Q4 2022 Earnings Conference Call. At this time, all participants on the listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during that session, you'll need to press star 1-1 on your phone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded, and I would now like to hand the conference over to your speaker today, Ms. Theresa Ferguson, Senior Director of Marketing for Predictive Oncology. Ms. Ferguson, please go ahead.

Thank you. Welcome, and thank you, everyone, for dialing in. Today we'll share about our latest updates. First, you're going to hear from our Chief Executive Officer and Chairman of the Board, Raymond Benary, then our Chief Financial Officer, Bob Myers will give you an overview about our financials. Finally, Dr. Pamela Bush, our Chief Business Officer, will join Raymond and Bob during the Q&A portion. Certain matters discussed in this call contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties, and assumptions about our operations and the investments we make. All statements other than statements of historical facts included in the call regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, plans, and objectives of management are forward-looking statements. The words anticipate, believe, estimate, expect, intend, may, plan, would, target, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may material differ from that contemplated by the forward-looking statement as a result of a variety of factors, including, among other things, factors discussed under the heading risk factors in our filings with the FCC. Except as expressly required by law, the company disclaims any intent or obligation to update these forward-looking statements. Thank you for bearing with us with that and now we are going to welcome Raymond Benary and we'll get him on the line.

One moment please. Pardon me, Raymond Benary is now able to present.